Impacts of risk-stratified inpatient penicillin allergy label delabeling on subsequent antimicrobial spectrum index and costs

Impacts of risk-stratified inpatient penicillin allergy label delabeling on subsequent antimicrobial spectrum index and costs

Penicillin allergy delabeling may benefit antimicrobial stewardship (AS). Cost of initial penicillin treatments following risk-stratified inpatient delabeling were compared to two hypothetical treatment regimens if delabeling had not occurred: (1) AS-guided and (2) Common Treatment. Penicillin aller...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Antimicrobial stewardship & healthcare epidemiology : ASHE 2024, Vol.4 (1), p.e160, Article e160
Hauptverfasser: Staub, Milner, Nelson, George E, Byrge, Kelly, Koo, Grace, Nesbitt, Whitney J, Stollings, Joanna L, Zhang, Minhua, Stone, Jr, Cosby A
Format: Artikel
Sprache:eng
Schlagworte:
Allergies
Antibiotics
Cost control
Health risks
Infections
Medical treatment
Patients
Penicillin
Side effects
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Penicillin allergy delabeling may benefit antimicrobial stewardship (AS). Cost of initial penicillin treatments following risk-stratified inpatient delabeling were compared to two hypothetical treatment regimens if delabeling had not occurred: (1) AS-guided and (2) Common Treatment. Penicillin allergy delabeling improved antimicrobial spectrum index, was cost-neutral, and averted unnecessary penicillin desensitizations.
ISSN:2732-494X
2732-494X
DOI:10.1017/ash.2024.421